The present study highlights the links existing between the folate metabolic pathway and the promoter methylation levels of the maintenance DNMT, suggesting that further studies are required to address this issue in human disorders characterized by changes in DNMT1 promoter methylation, such as hematological malignancies, solid tumors, and autoimmune/inflammatory diseases. The gene discussed is DNMT1; the disease is hematologic disorder.